打造以疾病为中心的止血与血栓闭环解决方案  

Create a disease centered closed-loop coagulation test solution

作　　者：吴俊[1] Wu Jun(Department of laboratory medicine,Beijing Jishuitan Hospital,Beijing100035,China)

机构地区：[1]北京积水潭医院检验医学中心,北京100035

出　　处：《中华检验医学杂志》2022年第10期997-999,共3页Chinese Journal of Laboratory Medicine

摘　　要：止血与血栓涉及临床所有学科,是临床患者常见死亡原因,对于临床各科疾病提供有效的解决方案,是提高临床诊疗水平的重要环节。由于出血与血栓性疾病,最重要的诊断就是实验室诊断,因此。加强实验室诊断能力建设,是协助临床有效诊疗的关键环节。未来止血与血栓发展主要方向是关注国际止血与血栓行业进步,加强专家共识和止血与血栓标准化建设,以疾病为中心,而不是以项目为中心,密切围绕临床需求和问题,提供实验诊断的整体、闭环解决方案。主动融合多学科共同发展,政、产、学、研、用协作共赢,共同打造中国止血与血栓发展的良好生态。Thrombosis and hemostasis, related to many clinical disciplines, are common causes of death observed in clinics. An effective clinical management strategy is composed of effective clinical diagnosis and treatment. Because thrombosis and hemorrhagic diseases is primarily identified through diagnostic testing, improving capacity of clinical laboratory testing plays a key role in supporting clinical diagnosis and treatment. The major considerations for improving coagulation diagnostic testing in the future include closely following news on the global progress in thrombosis and hemostasis area, strengthening the inter-expert communications to reach consensus on the standardization of coagulation testing, and transitioning from test-centric model to disease-centric model for providing holistic and integrated vision to facilitate the improvement of clinical experimental diagnosis. Relevant multi-disciplinary function areas are encouraged to consistently cooperate, in collaboration with government, pharmaceutical industry, academia, research institution and health care provider, to create a healthy environment for the development of Chinese hemagglutination therapy paradigm.

关 键 词：止血 血栓形成 出凝血障碍 实验室检测 

分 类 号：R364.15[医药卫生—病理学]